Acceptability of an Interim Socket System (ASSIST)

September 26, 2024 updated by: University of Hull

Acceptability of an Interim Socket System in the Immediate Rehabilitation of People With a tranSTibial Amputation (ASSIST): A Pilot Study

This study will explore the acceptability of an interim socket system to new patients with a below-knee amputation and also to NHS healthcare providers.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

After a transtibial amputation, post-operative swelling, followed by muscle wasting, can lead to residual limb volume changes during the first 12 months. Managing this volume change often involves many socket modifications and/or replacement sockets. These multiple re-casts can be burdensome for the patient and delay recovery as patients are unable to mobilise and progress in an ill-fitting socket, leading to increased health resource use and costs.

An alternative technology exists involving an interim (aka confidence) socket whereby thermoplastic material is moulded onto the patient's residual limb and a socket is produced in a single session. This material can then be heated and remoulded quickly and comfortably, so that the patient accommodates to a single socket that can be adjusted as required to volume changes.

The confidence socket system could make the casting and prosthetic fitting process more efficient and cost-effective and improve the speed of delivery of the interim prosthesis. Thus a patient could start gait re-training with their confidence socket earlier compared to the standard treatment of fitting a laminate or polypropylene socket.

The aim of this pilot study is to assess the acceptability of the confidence socket to NHS healthcare providers and their patients, during an initial 3-month prosthetic fitting period.

Amputee participants will be recruited from 2 NHS sites. They will receive standard pre-prosthetic physiotherapy treatment until their primary MDT appointment, when they will be cast for their first prosthesis using the confidence socket which will replace standard care with the usual socket. Prescription of prosthetic foot components will continue as per usual care. Once the confidence socket is complete the patient will begin treatment according to usual physiotherapy rehabilitation. Amputee participants will be interviewed about their experience of receiving treatment with the confidence socket.

Healthcare providers delivering the treatment will also be interviewed about their acceptability of the confidence socket within the NHS pathways.

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bournemouth, United Kingdom, BH7 7DW
        • University Hospitals Dorset NHS Foundation Trust
      • Portsmouth, United Kingdom, PO3 6AD
        • Portsmouth Hospitals University NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Over the age of 18
  • New transtibial amputation within the last 6 months
  • Deemed ready to cast for a prosthesis by the clinical team as per usual care at the prosthetic centre
  • Able to understand written English and provide informed consent

Exclusion Criteria:

  • Participants under the age of 18
  • Participants with an ankle disarticulation, Knee disarticulation or transfemoral amputation
  • Body mass > 125 kg with a distal circumference of 23-34 cm (small socket)
  • Body mass > 150 kg with a distal circumference of 30-45 cm (large socket)
  • Residual limb longer than 27 cm
  • Severe upper limb dysfunction (due to strength requirements to don the liner)
  • Severe visual requirements (that would restrict the person's ability to monitor their residual limb)
  • Contraindication to be fit for a prosthetic socket
  • Recent cerebrovascular event (i.e., stroke, haemorrhage, brain injury)
  • Disease affecting their memory
  • Unwilling to trial the confidence socket system
  • Unable to tolerate wearing a prosthetic liner due to excess sweating/ allergic reaction or other reasons

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Confidence socket
Participants to receive a confidence socket system
Confidence socket involves thermoplastic material being moulded onto the patient's residual limb and a socket is produced in a single session. The socket can be remoulded to adjust to changes in residual limb volume.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Socket comfort score
Time Frame: Up to 6 months
Patient-reported socket comfort
Up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in EQ-5D-5L
Time Frame: Up to 6 months
Health related quality of life
Up to 6 months
Change in Locomotor Capabilities Index (LCI-5)
Time Frame: Up to 6 months
LCI-5 with prosthesis
Up to 6 months
Change in Activities Balance Confidence-UK (ABC-UK)
Time Frame: Up to 6 months
Balance confidence
Up to 6 months
Change in L-test
Time Frame: Up to 6 months
Functional timed up and go L-test
Up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2021

Primary Completion (Estimated)

November 28, 2024

Study Completion (Estimated)

November 28, 2024

Study Registration Dates

First Submitted

December 6, 2021

First Submitted That Met QC Criteria

January 4, 2022

First Posted (Actual)

January 19, 2022

Study Record Updates

Last Update Posted (Actual)

September 27, 2024

Last Update Submitted That Met QC Criteria

September 26, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RS149-291816-NV

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on Amparo confidence socket

Subscribe